Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Joshua

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Current Oncology (Toronto, Ont.)|July 7, 2017
Resource utilization and costs of managing patients with advanced melanoma: a Canadian population-based studyF Gwadry-Sridhar, S Nikan, A Hamou, et al.
Cancer Chemotherapy and Pharmacology|January 19, 2024
Correction to: Up-regulation of autophagy is a mechanism of resistance to chemotherapy and can be inhibited by pantoprazole to increase drug sensitivityQian Tan, A M Joshua, M Wang, et al.
The Prostate|October 30, 2010
Topographical analysis of telomere length and correlation with genomic instability in whole mount prostatectomiesA M Joshua, E Shen, M Yoshimoto, et al.
British Journal of Cancer|February 4, 2015
Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagyQ Tan, A M Joshua, J K Saggar, et al.
British Journal of Cancer|March 21, 2024
Retraction Note: Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagyQ Tan, A M Joshua, J K Saggar, et al.
Skin Health and Disease|June 6, 2022
Cutaneous sarcoidosis due to immune-checkpoint inhibition and exacerbated by a novel BRAF dimerization inhibitorJ P Pham, P Star, S Wong, et al.
Prostate Cancer and Prostatic Diseases|June 10, 2021
Barriers and facilitators related to undertaking physical activities among men with prostate cancer: a scoping reviewS Sattar, K R Haase, C Bradley, et al.
Prostate Cancer and Prostatic Diseases|May 28, 2014
A pilot 'window of opportunity' neoadjuvant study of metformin in localised prostate cancerA M Joshua, V E Zannella, M R Downes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2013
Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trialsA J Templeton, F E Vera-Badillo, L Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 25, 2014
Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancerR Leibowitz-Amit, A J Templeton, A Omlin, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Current Oncology (Toronto, Ont.)|July 7, 2017
Resource utilization and costs of managing patients with advanced melanoma: a Canadian population-based studyF Gwadry-Sridhar, S Nikan, A Hamou, et al.
Cancer Chemotherapy and Pharmacology|January 19, 2024
Correction to: Up-regulation of autophagy is a mechanism of resistance to chemotherapy and can be inhibited by pantoprazole to increase drug sensitivityQian Tan, A M Joshua, M Wang, et al.
The Prostate|October 30, 2010
Topographical analysis of telomere length and correlation with genomic instability in whole mount prostatectomiesA M Joshua, E Shen, M Yoshimoto, et al.
British Journal of Cancer|February 4, 2015
Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagyQ Tan, A M Joshua, J K Saggar, et al.
British Journal of Cancer|March 21, 2024
Retraction Note: Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagyQ Tan, A M Joshua, J K Saggar, et al.
Skin Health and Disease|June 6, 2022
Cutaneous sarcoidosis due to immune-checkpoint inhibition and exacerbated by a novel BRAF dimerization inhibitorJ P Pham, P Star, S Wong, et al.
Prostate Cancer and Prostatic Diseases|June 10, 2021
Barriers and facilitators related to undertaking physical activities among men with prostate cancer: a scoping reviewS Sattar, K R Haase, C Bradley, et al.
Prostate Cancer and Prostatic Diseases|May 28, 2014
A pilot 'window of opportunity' neoadjuvant study of metformin in localised prostate cancerA M Joshua, V E Zannella, M R Downes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2013
Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trialsA J Templeton, F E Vera-Badillo, L Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 25, 2014
Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancerR Leibowitz-Amit, A J Templeton, A Omlin, et al.
Pageof 4